The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

Inclusion Criteria: * Men and women of any ethnicity. * Age Range - 18 - 85 (inclusive) * Participant must be able to comply with treatment plan and laboratory tests including ability and willingness to perform home venous blood draw using Tasso device. * Participant must be able to read, write and speak English fluently * Participant must have an established primary care provider * Participant must be willing and able to consume 4 capsules per day throughout the duration of study period Exclusion Criteria: * History or presence of cancer in the prior 2 years, except for non-melanoma skin cancer. * Known immune system issues or immunodeficiency disease * History of viral illness which could be reactivated by immune downregulation * Presence of clinically significant acute or unstable cardiovascular and cerebrovascular (stroke) disease * Diagnosis of a transient ischemic attack in the 6 months prior to screening * Participants infected with hepatitis C or HIV * Body Mass Index (BMI) greater than or equal to 40 kilograms per meter squared * Presence of active infection in previous 4 weeks * Any other illness, psychiatric disorder, alcohol or chemical dependence that in the opinion of the Clinical Investigator would render a participant unsuitable to participate in the study * Unable or unwilling to provide required blood sample for testing * Current or previous use of known prescription immunomodulating products (e.g. glucocorticoids, tumor necrosis factor (TNF)-alpha inhibi…